Monsanto Co. (MON) Given a $128.00 Price Target at JPMorgan Chase & Co.
Other equities analysts have also recently issued reports about the stock. Credit Agricole SA reiterated a buy rating on shares of Monsanto in a research note on Saturday, July 2nd. Vetr cut shares of Monsanto from a strong-buy rating to a buy rating and set a $116.47 target price for the company. in a research note on Thursday, July 14th. Deutsche Bank AG reiterated a buy rating and issued a $118.00 target price on shares of Monsanto in a research note on Thursday, June 30th. Jefferies Group reiterated a buy rating on shares of Monsanto in a research note on Wednesday, June 29th. Finally, Argus restated a buy rating and set a $128.00 price objective (up from $111.00) on shares of Monsanto in a research report on Wednesday, June 15th. Three research analysts have rated the stock with a sell rating, eight have assigned a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the stock. Monsanto currently has a consensus rating of Buy and an average target price of $114.67.
Shares of Monsanto (NYSE:MON) traded down 0.10% during trading on Thursday, hitting $103.40. 1,633,739 shares of the company’s stock were exchanged. The company has a market cap of $45.25 billion, a P/E ratio of 45.51 and a beta of 1.19. Monsanto has a 12-month low of $83.73 and a 12-month high of $114.26. The company has a 50-day moving average of $104.88 and a 200-day moving average of $101.34.
Monsanto (NYSE:MON) last posted its earnings results on Wednesday, October 5th. The company reported $0.07 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.02) by $0.09. Monsanto had a net margin of 9.89% and a return on equity of 46.07%. The firm earned $2.56 billion during the quarter, compared to analysts’ expectations of $2.38 billion. During the same period in the previous year, the business posted ($0.19) EPS. The business’s revenue was up 8.8% compared to the same quarter last year. On average, equities analysts expect that Monsanto will post $4.89 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 28th. Shareholders of record on Friday, October 7th will be issued a dividend of $0.54 per share. The ex-dividend date of this dividend is Wednesday, October 5th. This represents a $2.16 dividend on an annualized basis and a yield of 2.09%. Monsanto’s payout ratio is currently 71.05%.
In other Monsanto news, CEO Michael K. Stern sold 12,797 shares of the firm’s stock in a transaction that occurred on Wednesday, July 13th. The shares were sold at an average price of $101.77, for a total transaction of $1,302,350.69. Following the sale, the chief executive officer now owns 21,583 shares of the company’s stock, valued at $2,196,501.91. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, COO Brett D. Begemann sold 27,980 shares of the firm’s stock in a transaction that occurred on Thursday, July 14th. The stock was sold at an average price of $103.62, for a total transaction of $2,899,287.60. Following the sale, the chief operating officer now directly owns 102,480 shares in the company, valued at approximately $10,618,977.60. The disclosure for this sale can be found here. Company insiders own 0.88% of the company’s stock.
A number of hedge funds have recently added to or reduced their stakes in the company. Franklin Street Advisors Inc. NC boosted its stake in Monsanto by 24.7% in the third quarter. Franklin Street Advisors Inc. NC now owns 62,980 shares of the company’s stock worth $6,437,000 after buying an additional 12,475 shares during the last quarter. Acropolis Investment Management LLC boosted its stake in Monsanto by 4.0% in the third quarter. Acropolis Investment Management LLC now owns 3,319 shares of the company’s stock worth $339,000 after buying an additional 127 shares during the last quarter. Burke & Herbert Bank & Trust Co. boosted its stake in Monsanto by 5.5% in the third quarter. Burke & Herbert Bank & Trust Co. now owns 2,606 shares of the company’s stock worth $266,000 after buying an additional 137 shares during the last quarter. BNP Paribas Arbitrage SA boosted its stake in Monsanto by 5.2% in the third quarter. BNP Paribas Arbitrage SA now owns 308,850 shares of the company’s stock worth $31,564,000 after buying an additional 15,128 shares during the last quarter. Finally, Beacon Financial Group boosted its stake in Monsanto by 93.9% in the third quarter. Beacon Financial Group now owns 26,832 shares of the company’s stock worth $2,731,000 after buying an additional 12,993 shares during the last quarter. 79.02% of the stock is currently owned by institutional investors.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Stock Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related stocks with our FREE daily email newsletter.